The RNAi interference (RNAi) pathway has excited biologists and clinicians, since it provides a means to silence nearly any gene, include pathogenic gene expression. This is because the active intermediates, the small interfering RNAs (siRNAs) have great promise as therapeutics. The proposed studies intend to advance our basic understanding of the RNAi pathway and at the same time develop powerful tools for performing silencing by small RNAs. The proposed studies are geared towards the analysis of the activity of siRNAs on DNA. We describe a novel method to inexpensively and rapidly generate thousands of specific short hairpin (shRNA) targeting any gene, thus bypassing a common limitation in RNAi experiments. We have developed a mouse model for studying RNAi pathways and will use this to explore the mechanism behind silencing of repetitive DNA via formation of small-RNA directed heterochromatin. In addition, we will the above systems to explore the importance of position and sequence of the shRNA and cognate target site on the DNA. Finally, we describe the production of mice that report on the ectopic introduction of a silencing RNA. We envision that this mouse will be an important reagent for testing the uptake and activity of siRNAs in specific tissues, which is an important if siRNAs are to become use in therapeutic intervention of human disease. Lay language relevance to public heath: The introduction of double-stranded RNA into an organism causes specific interference of gene expression termed RNA interference (RNAi). Unfortunately much remains to be understood regarding the RNAi pathway in cells, especially how to achieve RNAi in cells and tissues. These studies describe our efforts to develop new means of performing RNAi in mouse models and should shed insight into the biology of small RNAs. Our studies are unique since we exploit the activity of small RNAs in the nucleus, where we can prevent pathogenic genes from being expressed from the DNA.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM080783-05
Application #
8018676
Study Section
Special Emphasis Panel (ZRG1-BST-Z (52))
Program Officer
Bender, Michael T
Project Start
2007-02-01
Project End
2014-01-31
Budget Start
2011-02-01
Budget End
2014-01-31
Support Year
5
Fiscal Year
2011
Total Cost
$287,709
Indirect Cost
Name
University of California San Francisco
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
094878337
City
San Francisco
State
CA
Country
United States
Zip Code
94143
Mattis, Aras N; Song, Guisheng; Hitchner, Kelly et al. (2015) A screen in mice uncovers repression of lipoprotein lipase by microRNA-29a as a mechanism for lipid distribution away from the liver. Hepatology 61:141-52
Qin, Han; Diaz, Aaron; Blouin, Laure et al. (2014) Systematic identification of barriers to human iPSC generation. Cell 158:449-61
van de Weijer, Michael L; Bassik, Michael C; Luteijn, Rutger D et al. (2014) A high-coverage shRNA screen identifies TMEM129 as an E3 ligase involved in ER-associated protein degradation. Nat Commun 5:3832
Matheny, Christina J; Wei, Michael C; Bassik, Michael C et al. (2013) Next-generation NAMPT inhibitors identified by sequential high-throughput phenotypic chemical and functional genomic screens. Chem Biol 20:1352-63
Bassik, Michael C; Kampmann, Martin; Lebbink, Robert Jan et al. (2013) A systematic mammalian genetic interaction map reveals pathways underlying ricin susceptibility. Cell 152:909-22
Upton, John-Paul; Wang, Likun; Han, Dan et al. (2012) IRE1ýý cleaves select microRNAs during ER stress to derepress translation of proapoptotic Caspase-2. Science 338:818-22
Ku, Gregory M; Pappalardo, Zachary; Luo, Chun Chieh et al. (2012) An siRNA screen in pancreatic beta cells reveals a role for Gpr27 in insulin production. PLoS Genet 8:e1002449
Dallas, Anne; Ilves, Heini; Ge, Qing et al. (2012) Right- and left-loop short shRNAs have distinct and unusual mechanisms of gene silencing. Nucleic Acids Res 40:9255-71
Lebbink, Robert Jan; Lowe, Maggie; Chan, Theresa et al. (2011) Polymerase II promoter strength determines efficacy of microRNA adapted shRNAs. PLoS One 6:e26213
Tan, Grace S; Garchow, Barry G; Liu, Xuhang et al. (2009) Expanded RNA-binding activities of mammalian Argonaute 2. Nucleic Acids Res 37:7533-45

Showing the most recent 10 out of 12 publications